211 related articles for article (PubMed ID: 24870743)
1. Inflammatory bowel disease and risk of cholangiocarcinoma: evidence from a meta-analysis of population-based studies.
Huai JP; Ding J; Ye XH; Chen YP
Asian Pac J Cancer Prev; 2014; 15(8):3477-82. PubMed ID: 24870743
[TBL] [Abstract][Full Text] [Related]
2. Incidence and prognosis of cholangiocarcinoma in Danish patients with and without inflammatory bowel disease: a national cohort study, 1978-2003.
Erichsen R; Jepsen P; Vilstrup H; Ekbom A; Sørensen HT
Eur J Epidemiol; 2009; 24(9):513-20. PubMed ID: 19557525
[TBL] [Abstract][Full Text] [Related]
3. Hepatobiliary Cancer Risk in Patients with Inflammatory Bowel Disease: A Scandinavian Population-Based Cohort Study.
Erichsen R; Olén O; Sachs MC; Pedersen L; Halfvarson J; Askling J; Ekbom A; Ludvigsson JF; Sørensen HT
Cancer Epidemiol Biomarkers Prev; 2021 May; 30(5):886-894. PubMed ID: 33627380
[TBL] [Abstract][Full Text] [Related]
4. Smoking, alcohol consumption, and the risk of extrahepatic cholangiocarcinoma: a meta-analysis.
Ye XH; Huai JP; Ding J; Chen YP; Sun XC
World J Gastroenterol; 2013 Dec; 19(46):8780-8. PubMed ID: 24379600
[TBL] [Abstract][Full Text] [Related]
5. Hepatitis B virus infection increases the risk of cholangiocarcinoma: a meta-analysis and systematic review.
Li M; Li J; Li P; Li H; Su T; Zhu R; Gong J
J Gastroenterol Hepatol; 2012 Oct; 27(10):1561-8. PubMed ID: 22694354
[TBL] [Abstract][Full Text] [Related]
6. Diabetes mellitus and increased risk of cholangiocarcinoma: a meta-analysis.
Jing W; Jin G; Zhou X; Zhou Y; Zhang Y; Shao C; Liu R; Hu X
Eur J Cancer Prev; 2012 Jan; 21(1):24-31. PubMed ID: 21857525
[TBL] [Abstract][Full Text] [Related]
7. Diabetes mellitus and increased risk of extrahepatic cholangiocarcinoma: a meta-analysis.
Zhang LF; Zhao HX
Hepatogastroenterology; 2013 Jun; 60(124):684-7. PubMed ID: 23321031
[TBL] [Abstract][Full Text] [Related]
8. Association Between Inflammatory Bowel Diseases and Celiac Disease: A Systematic Review and Meta-Analysis.
Pinto-Sanchez MI; Seiler CL; Santesso N; Alaedini A; Semrad C; Lee AR; Bercik P; Lebwohl B; Leffler DA; Kelly CP; Moayyedi P; Green PH; Verdu EF
Gastroenterology; 2020 Sep; 159(3):884-903.e31. PubMed ID: 32416141
[TBL] [Abstract][Full Text] [Related]
9. Risk of extra-intestinal cancer in inflammatory bowel disease: meta-analysis of population-based cohort studies.
Pedersen N; Duricova D; Elkjaer M; Gamborg M; Munkholm P; Jess T
Am J Gastroenterol; 2010 Jul; 105(7):1480-7. PubMed ID: 20332773
[TBL] [Abstract][Full Text] [Related]
10. Increased risk of stroke among patients with inflammatory bowel disease: A PRISMA-compliant meta-analysis.
Chen Y; Wang X
Brain Behav; 2021 Jun; 11(6):e02159. PubMed ID: 33960728
[TBL] [Abstract][Full Text] [Related]
11. Risk factors for intrahepatic and extrahepatic cholangiocarcinoma in the United States: a population-based case-control study.
Welzel TM; Graubard BI; El-Serag HB; Shaib YH; Hsing AW; Davila JA; McGlynn KA
Clin Gastroenterol Hepatol; 2007 Oct; 5(10):1221-8. PubMed ID: 17689296
[TBL] [Abstract][Full Text] [Related]
12. Primary sclerosing cholangitis associated with inflammatory bowel disease: an observational study in a Southern Europe population focusing on new therapeutic options.
Franceschet I; Cazzagon N; Del Ross T; D'Incà R; Buja A; Floreani A
Eur J Gastroenterol Hepatol; 2016 May; 28(5):508-13. PubMed ID: 26872110
[TBL] [Abstract][Full Text] [Related]
13. Inflammatory bowel disease is associated with an increased risk of melanoma: a systematic review and meta-analysis.
Singh S; Nagpal SJ; Murad MH; Yadav S; Kane SV; Pardi DS; Talwalkar JA; Loftus EV
Clin Gastroenterol Hepatol; 2014 Feb; 12(2):210-8. PubMed ID: 23644389
[TBL] [Abstract][Full Text] [Related]
14. Cancer in Elderly Onset Inflammatory Bowel Disease: A Population-Based Study.
Cheddani H; Dauchet L; Fumery M; Charpentier C; Marie Bouvier A; Dupas JL; Pariente B; Peyrin-Biroulet L; Savoye G; Gower-Rousseau C
Am J Gastroenterol; 2016 Oct; 111(10):1428-1436. PubMed ID: 27481308
[TBL] [Abstract][Full Text] [Related]
15. Hepatitis C virus infection and the risk of intrahepatic cholangiocarcinoma and extrahepatic cholangiocarcinoma: evidence from a systematic review and meta-analysis of 16 case-control studies.
Li H; Hu B; Zhou ZQ; Guan J; Zhang ZY; Zhou GW
World J Surg Oncol; 2015 Apr; 13():161. PubMed ID: 25903488
[TBL] [Abstract][Full Text] [Related]
16. Risk of Cervical Cancer in Inflammatory Bowel Disease: A Meta-Analysis of Population-Based Studies.
Mann S; Jess T; Allin K; Elmahdi R
Clin Transl Gastroenterol; 2022 Jul; 13(7):e00513. PubMed ID: 35905421
[TBL] [Abstract][Full Text] [Related]
17. Tolerability of selective cyclooxygenase 2 inhibitors used for the treatment of rheumatological manifestations of inflammatory bowel disease.
Miao XP; Li JS; Ouyang Q; Hu RW; Zhang Y; Li HY
Cochrane Database Syst Rev; 2014 Oct; (10):CD007744. PubMed ID: 25340915
[TBL] [Abstract][Full Text] [Related]
18. Risk factors for intrahepatic cholangiocarcinoma in a low-risk population: a nationwide case-control study.
Welzel TM; Mellemkjaer L; Gloria G; Sakoda LC; Hsing AW; El Ghormli L; Olsen JH; McGlynn KA
Int J Cancer; 2007 Feb; 120(3):638-41. PubMed ID: 17109384
[TBL] [Abstract][Full Text] [Related]
19. Increased risk of ischemic heart disease and diabetes in inflammatory bowel disease.
Li Z; Qiao L; Yun X; Du F; Xing S; Yang M
Z Gastroenterol; 2021 Feb; 59(2):117-124. PubMed ID: 33233007
[TBL] [Abstract][Full Text] [Related]
20. Inflammatory bowel disease and cardiovascular disease incidence and mortality: A meta-analysis.
Sun HH; Tian F
Eur J Prev Cardiol; 2018 Oct; 25(15):1623-1631. PubMed ID: 30074405
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
